首页 > 最新文献

Zhonghua yi xue za zhi = Chinese medical journal; Free China ed最新文献

英文 中文
Minimally invasive cardiac surgery for resection of right atrial hepatic tumor in an octogenarian. 微创心脏手术切除八旬老人右房肝肿瘤1例。
Tsung-Po Tsai, Jung-Min Yu

Removal of right atrial hepatic tumor with caval involvement requires control of bleeding, avoidance of tumor embolization, and adequate resection. We reported an octogenarian having hepatocellular carcinoma with caval and right atrial involvements who underwent successful resection using cardiopulmonary bypass and intraoperative transesophageal echocardiography.

切除侵犯腔静脉的右心房肝肿瘤需要控制出血,避免肿瘤栓塞,并充分切除。我们报告了一位八十多岁的肝癌伴腔室和右心房受累者,他成功地接受了体外循环和术中经食管超声心动图的切除。
{"title":"Minimally invasive cardiac surgery for resection of right atrial hepatic tumor in an octogenarian.","authors":"Tsung-Po Tsai,&nbsp;Jung-Min Yu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Removal of right atrial hepatic tumor with caval involvement requires control of bleeding, avoidance of tumor embolization, and adequate resection. We reported an octogenarian having hepatocellular carcinoma with caval and right atrial involvements who underwent successful resection using cardiopulmonary bypass and intraoperative transesophageal echocardiography.</p>","PeriodicalId":24073,"journal":{"name":"Zhonghua yi xue za zhi = Chinese medical journal; Free China ed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22054794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stroke registry in Kaohsiung Veterans General Hospital. 高雄退伍军人总医院脑卒中登记处。
Yuh-Te Lin, Yuk-Keung Lo, Hun-Chang Kuo, Yun-Te Chang, Ming-Hong Chang, Jieh-Yuan Li

Background: Stroke ranks as the second major cause of death in Taiwan. For better understanding of stroke characteristics in southern Taiwan and to provide further information to other studies of stroke, we reviewed the clinical data of our in-patients with acute stroke.

Methods: Patients who were admitted to our hospital due to acute stroke between January 1999 and December 1999 were enrolled in our study. We used a stroke registration form to collect clinical data, including laboratory data, stroke subtype, risk factors, neurosonographic result, treatment, related complications, and Rankin Scale. Chi-square test was used to compare clinical parameters among the stroke patients.

Results: A total of 578 patients with acute stroke were enrolled in our study. Among 578 patients, 408 (71%) patients were of ischemic stroke and 170 (29%) patients were of hemorrhagic stroke type. In the ischemic stroke group, the prevalence rate of risk factors were hypertension (71%), intracranial arterial stenosis (41%), diabetes mellitus (37%), current smoking (30%), hyperlipidemia (30%), atrial fibrillation (15%) and extracranial carotid stenosis (15%). Hypertension (79%) and diabetes (17%) were also major risk factors in hemorrhagic stroke patients. The in-hospital case-fatality rate for ischemic stroke (8.8%) was less than that for hemorrhagic stroke (20.6%).

Conclusions: The proportion of hemorrhagic stroke in our acute stroke patients was higher in comparison to western countries. Hypertension, diabetes, smoking and hyperlipidemia were major modifiable risk factors in ischemic stroke. Better control of such risk factors is an important issue in either primary or secondary prevention of stroke. In our study, intracranial arterial stenosis (41%) was more common than extracranial carotid stenosis (15%). The result was different from western stroke registration. The cause is worth further study.

背景:中风是台湾第二大死因。为了更好地了解台湾南部地区的脑卒中特征,并为其他脑卒中研究提供进一步的信息,我们回顾了急性脑卒中住院患者的临床资料。方法:选取1999年1月至1999年12月间我院收治的急性脑卒中患者为研究对象。我们使用卒中登记表收集临床资料,包括实验室资料、卒中亚型、危险因素、神经超声结果、治疗、相关并发症和Rankin量表。采用卡方检验比较脑卒中患者的临床参数。结果:578例急性脑卒中患者入组研究。578例患者中,缺血性卒中408例(71%),出血性卒中170例(29%)。缺血性卒中组的危险因素患病率为高血压(71%)、颅内动脉狭窄(41%)、糖尿病(37%)、吸烟(30%)、高脂血症(30%)、房颤(15%)、颈动脉颅外狭窄(15%)。高血压(79%)和糖尿病(17%)也是出血性卒中患者的主要危险因素。缺血性卒中住院病死率(8.8%)低于出血性卒中住院病死率(20.6%)。结论:我国急性脑卒中患者出血性脑卒中比例高于西方国家。高血压、糖尿病、吸烟和高脂血症是缺血性脑卒中的主要可改变危险因素。更好地控制这些危险因素是卒中一级或二级预防的重要问题。在我们的研究中,颅内动脉狭窄(41%)比颅外颈动脉狭窄(15%)更常见。结果与西方的笔画配准不同。原因值得进一步研究。
{"title":"Stroke registry in Kaohsiung Veterans General Hospital.","authors":"Yuh-Te Lin,&nbsp;Yuk-Keung Lo,&nbsp;Hun-Chang Kuo,&nbsp;Yun-Te Chang,&nbsp;Ming-Hong Chang,&nbsp;Jieh-Yuan Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Stroke ranks as the second major cause of death in Taiwan. For better understanding of stroke characteristics in southern Taiwan and to provide further information to other studies of stroke, we reviewed the clinical data of our in-patients with acute stroke.</p><p><strong>Methods: </strong>Patients who were admitted to our hospital due to acute stroke between January 1999 and December 1999 were enrolled in our study. We used a stroke registration form to collect clinical data, including laboratory data, stroke subtype, risk factors, neurosonographic result, treatment, related complications, and Rankin Scale. Chi-square test was used to compare clinical parameters among the stroke patients.</p><p><strong>Results: </strong>A total of 578 patients with acute stroke were enrolled in our study. Among 578 patients, 408 (71%) patients were of ischemic stroke and 170 (29%) patients were of hemorrhagic stroke type. In the ischemic stroke group, the prevalence rate of risk factors were hypertension (71%), intracranial arterial stenosis (41%), diabetes mellitus (37%), current smoking (30%), hyperlipidemia (30%), atrial fibrillation (15%) and extracranial carotid stenosis (15%). Hypertension (79%) and diabetes (17%) were also major risk factors in hemorrhagic stroke patients. The in-hospital case-fatality rate for ischemic stroke (8.8%) was less than that for hemorrhagic stroke (20.6%).</p><p><strong>Conclusions: </strong>The proportion of hemorrhagic stroke in our acute stroke patients was higher in comparison to western countries. Hypertension, diabetes, smoking and hyperlipidemia were major modifiable risk factors in ischemic stroke. Better control of such risk factors is an important issue in either primary or secondary prevention of stroke. In our study, intracranial arterial stenosis (41%) was more common than extracranial carotid stenosis (15%). The result was different from western stroke registration. The cause is worth further study.</p>","PeriodicalId":24073,"journal":{"name":"Zhonghua yi xue za zhi = Chinese medical journal; Free China ed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22053709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intra-extracranial hemangiopericytoma: clinical manifestations, histopathological features, diagnosis, treatment, and outcomes. 颅内外血管外皮细胞瘤:临床表现、组织病理特征、诊断、治疗及预后。
Hsi-Kai Tso, Yeou-Chih Wang, Dar-Yu Yang, Shan-Hua Wei

Background: Intra-extracranial hemangiopericytomas (HPCs) are rare vascular neoplasms. This paper reports the clinical manifestations, histopathological features, diagnosis, treatment, and outcomes of HPCs.

Methods: We reviewed three patients with intracranial HPC and one patient with HPC of the scalp who were surgically treated at Taichung Veterans General Hospital between 1989 and 1999.

Results: All four patients underwent surgery and postoperative radiotherapy. After surgery, three patients showed improvement compared with their preoperative neurological function. Two patients had recurrent tumors, one patient was well and free from tumor recurrence, and one patient was lost during follow-up.

Conclusions: Clinical presentation and radiographic appearance of intracranial HPC can be indistinguishable from meningioma. Intracranial HPC is an aggressive neoplasm with malignant potential. Both benign and malignant variations of HPC of the scalp exist. The principal treatment is surgical excision. Survival is influenced by more aggressive primary resection and by postoperative radiotherapy. Recurrences are common. Metastases may be multiple and can develop in many organs and systems.

背景:颅内外血管外皮细胞瘤(HPCs)是一种罕见的血管肿瘤。本文报道HPCs的临床表现、组织病理学特征、诊断、治疗及转归。方法:回顾1989 ~ 1999年在台中退伍军人总医院手术治疗的3例颅内HPC和1例头皮HPC。结果:4例患者均行手术治疗及术后放疗。手术后,3例患者的神经功能较术前有所改善。2例患者肿瘤复发,1例患者健康无复发,1例患者在随访中丢失。结论:颅内HPC的临床表现和影像学表现与脑膜瘤难以区分。颅内HPC是一种具有恶性潜能的侵袭性肿瘤。头皮HPC有良性和恶性两种类型。主要的治疗方法是手术切除。更积极的初次切除和术后放疗对生存率有影响。递归是常见的。转移可能是多发的,可以在许多器官和系统中发展。
{"title":"Intra-extracranial hemangiopericytoma: clinical manifestations, histopathological features, diagnosis, treatment, and outcomes.","authors":"Hsi-Kai Tso,&nbsp;Yeou-Chih Wang,&nbsp;Dar-Yu Yang,&nbsp;Shan-Hua Wei","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Intra-extracranial hemangiopericytomas (HPCs) are rare vascular neoplasms. This paper reports the clinical manifestations, histopathological features, diagnosis, treatment, and outcomes of HPCs.</p><p><strong>Methods: </strong>We reviewed three patients with intracranial HPC and one patient with HPC of the scalp who were surgically treated at Taichung Veterans General Hospital between 1989 and 1999.</p><p><strong>Results: </strong>All four patients underwent surgery and postoperative radiotherapy. After surgery, three patients showed improvement compared with their preoperative neurological function. Two patients had recurrent tumors, one patient was well and free from tumor recurrence, and one patient was lost during follow-up.</p><p><strong>Conclusions: </strong>Clinical presentation and radiographic appearance of intracranial HPC can be indistinguishable from meningioma. Intracranial HPC is an aggressive neoplasm with malignant potential. Both benign and malignant variations of HPC of the scalp exist. The principal treatment is surgical excision. Survival is influenced by more aggressive primary resection and by postoperative radiotherapy. Recurrences are common. Metastases may be multiple and can develop in many organs and systems.</p>","PeriodicalId":24073,"journal":{"name":"Zhonghua yi xue za zhi = Chinese medical journal; Free China ed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22053710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The in vitro inhibitory effect of flavonoid astilbin on 3-hydroxy-3-methylglutaryl coenzyme A reductase on Vero cells. 黄酮类乙酰胆碱对Vero细胞3-羟基-3-甲基戊二酰辅酶A还原酶的体外抑制作用。
Pub Date : 2000-12-01 DOI: 10.1046/J.1443-9506.2000.06978.X
T. H. Chen, J. C. Liu, J. Chang, M. Tsai, M. Hsieh, P. Chan
BACKGROUNDEpidemiological studies have shown that hypercholesterolemia is a major risk factor for coronary heart disease. In clinical trials of lipid lowering therapy, 3-hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) reductase inhibitor has been shown to decrease cardiac events and mortality. Flavonoids are polyphenolic natural antioxidants existing in vegetables, fruits and beverages such as tea and wine. Previous studies have shown that some antioxidants had hypocholesterolemic effect, and flavonoid intake was associated with the decrease of mortality from coronary artery disease. The aim of this study was to evaluate the inhibitory effect of flavonoids on HMG-CoA reductase.METHODSThe methods for analysis of specific inhibitors of mevalonate biosynthesis have been well-established, using Vero cells, a cell line obtained from kidneys of African green monkeys. Flavonoids isolated from different traditional Chinese herbs were dissolved in DMSO and incubated with Vero cells with or without the addition of 1 mM mevalonate or 5 mM sodium acetate in order to observe cell growth for 24 h.RESULTSConcentrations of 1 mM mevalonate or 5 mM sodium acetate were added into culture medium in order to observe the effect on cell growth. Different concentrations of pravastatin to inhibit cell growth were used as a positive control. About 40 flavonoid compounds were used for study, only one compound, astilbin (belonging to the flavonol group), showed significant inhibition of Vero cell growth.CONCLUSIONSThis study shows that one flavonoid compound, isolated from traditional medicinal herbs, may be an effective HMG-CoA reductase inhibitor which might be developed into a new hypocholesterolemic agent.
流行病学研究表明,高胆固醇血症是冠心病的主要危险因素。在降脂治疗的临床试验中,3-羟基-3-甲基戊二酰辅酶A (HMG-CoA)还原酶抑制剂已被证明可以降低心脏事件和死亡率。类黄酮是一种多酚类天然抗氧化剂,存在于蔬菜、水果和茶、酒等饮料中。先前的研究表明,一些抗氧化剂具有降低胆固醇的作用,类黄酮的摄入与冠状动脉疾病死亡率的降低有关。本研究旨在探讨黄酮类化合物对HMG-CoA还原酶的抑制作用。方法利用从非洲绿猴肾脏获得的Vero细胞,建立了甲羟戊酸生物合成特异性抑制剂的分析方法。将不同中草药中分离的黄酮类化合物溶解于DMSO中,加入或不加入1 mM甲羟戊酸或5 mM乙酸钠,与Vero细胞孵育24 h,观察细胞生长情况。结果在培养基中加入1 mM甲羟戊酸或5 mM乙酸钠,观察对细胞生长的影响。以不同浓度的普伐他汀抑制细胞生长作为阳性对照。约40种黄酮类化合物被用于研究,只有一种化合物,astilbin(属于黄酮醇组),具有显著的Vero细胞生长抑制作用。结论从传统中草药中分离得到的一种黄酮类化合物可能是一种有效的HMG-CoA还原酶抑制剂,可能成为一种新的降胆固醇药物。
{"title":"The in vitro inhibitory effect of flavonoid astilbin on 3-hydroxy-3-methylglutaryl coenzyme A reductase on Vero cells.","authors":"T. H. Chen, J. C. Liu, J. Chang, M. Tsai, M. Hsieh, P. Chan","doi":"10.1046/J.1443-9506.2000.06978.X","DOIUrl":"https://doi.org/10.1046/J.1443-9506.2000.06978.X","url":null,"abstract":"BACKGROUND\u0000Epidemiological studies have shown that hypercholesterolemia is a major risk factor for coronary heart disease. In clinical trials of lipid lowering therapy, 3-hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) reductase inhibitor has been shown to decrease cardiac events and mortality. Flavonoids are polyphenolic natural antioxidants existing in vegetables, fruits and beverages such as tea and wine. Previous studies have shown that some antioxidants had hypocholesterolemic effect, and flavonoid intake was associated with the decrease of mortality from coronary artery disease. The aim of this study was to evaluate the inhibitory effect of flavonoids on HMG-CoA reductase.\u0000\u0000\u0000METHODS\u0000The methods for analysis of specific inhibitors of mevalonate biosynthesis have been well-established, using Vero cells, a cell line obtained from kidneys of African green monkeys. Flavonoids isolated from different traditional Chinese herbs were dissolved in DMSO and incubated with Vero cells with or without the addition of 1 mM mevalonate or 5 mM sodium acetate in order to observe cell growth for 24 h.\u0000\u0000\u0000RESULTS\u0000Concentrations of 1 mM mevalonate or 5 mM sodium acetate were added into culture medium in order to observe the effect on cell growth. Different concentrations of pravastatin to inhibit cell growth were used as a positive control. About 40 flavonoid compounds were used for study, only one compound, astilbin (belonging to the flavonol group), showed significant inhibition of Vero cell growth.\u0000\u0000\u0000CONCLUSIONS\u0000This study shows that one flavonoid compound, isolated from traditional medicinal herbs, may be an effective HMG-CoA reductase inhibitor which might be developed into a new hypocholesterolemic agent.","PeriodicalId":24073,"journal":{"name":"Zhonghua yi xue za zhi = Chinese medical journal; Free China ed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87567452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Assessment of nutritional status in continuous ambulatory peritoneal dialysis patients: a comparison of bioelectric impedance and conventional methods. 评估连续非卧床腹膜透析患者的营养状况:生物电阻抗与常规方法的比较。
C H Cheng, M Y Chen, Y J Lee, M C Lee, K H Shu, M Y Wu, J D Lian

Background: Nutritional status is an important factor in long term continuous ambulatory peritoneal dialysis (CAPD) prognoses. Conventionally, serum albumin is an indicator of nutritional status. More recently, protein catabolic rate and lean body mass have been calculated during peritoneal equilibrium testing to assess nutritional status. These have the advantage of providing an early indication of malnutrition before the serum albumin decreases. Bioelectric impedance analysis (BIA) of nutrition has the advantage of being the simplest procedure among all nutritional assessments. Standard nutritional assessments was compared with the BIA method.

Methods: The protein catabolic rate and lean body mass was measured by the Keshaviah method. At the same time BIA was used to assess lean body mass, fat mass and fixed percentage of fat in 27 long-term CAPD patients, with and without peritoneal fluids.

Results: Among the 27 patients, the protein catabolic rate was 0.95+/-0.5 g/kg/day and lean body mass was 37.4+/-0.5 kg measured by the conventional method. Using BIA, the lean body mass was 37.8+/-11.0 kg with peritoneal dialysate, which was strongly correlated with the conventional method (p<0.001). BIA of lean body mass was 37.4+/-9.2 kg without peritoneal dialysate, which was also significantly correlated to the conventional method (p<0.001).

Conclusions: BIA nutritional assessment of lean body mass was comparable to the conventional method of nutritional assessment. The presence or absence of peritoneal dialysate did not influence the BIA method for detection of lean body mass. BIA has the advantage of being a more simple procedure and can be used for the long-term assessment of nutritional status in CAPD patients.

背景:营养状况是长期连续非卧床腹膜透析(CAPD)预后的重要因素。传统上,血清白蛋白是营养状况的指标。最近,在腹膜平衡测试中计算蛋白质分解代谢率和瘦体重来评估营养状况。这些方法的优点是在血清白蛋白减少之前提供营养不良的早期指示。营养的生物电阻抗分析(BIA)是所有营养评价中最简单的方法。将标准营养评价与BIA法进行比较。方法:采用Keshaviah法测定蛋白质分解代谢率和瘦体重。同时,应用BIA评估27例有或无腹膜液体的长期CAPD患者的瘦体重、脂肪质量和固定脂肪百分比。结果:27例患者中,常规方法测得蛋白质分解代谢率为0.95+/-0.5 g/kg/d,瘦体重为37.4+/-0.5 kg。经腹膜透析后,BIA的瘦体重为37.8+/-11.0 kg,与常规方法有很强的相关性(结论:BIA对瘦体重的营养评价与常规方法的营养评价相当)。腹膜透析液的存在与否不影响BIA法检测瘦体重。BIA的优点是操作更简单,可用于长期评估CAPD患者的营养状况。
{"title":"Assessment of nutritional status in continuous ambulatory peritoneal dialysis patients: a comparison of bioelectric impedance and conventional methods.","authors":"C H Cheng,&nbsp;M Y Chen,&nbsp;Y J Lee,&nbsp;M C Lee,&nbsp;K H Shu,&nbsp;M Y Wu,&nbsp;J D Lian","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Nutritional status is an important factor in long term continuous ambulatory peritoneal dialysis (CAPD) prognoses. Conventionally, serum albumin is an indicator of nutritional status. More recently, protein catabolic rate and lean body mass have been calculated during peritoneal equilibrium testing to assess nutritional status. These have the advantage of providing an early indication of malnutrition before the serum albumin decreases. Bioelectric impedance analysis (BIA) of nutrition has the advantage of being the simplest procedure among all nutritional assessments. Standard nutritional assessments was compared with the BIA method.</p><p><strong>Methods: </strong>The protein catabolic rate and lean body mass was measured by the Keshaviah method. At the same time BIA was used to assess lean body mass, fat mass and fixed percentage of fat in 27 long-term CAPD patients, with and without peritoneal fluids.</p><p><strong>Results: </strong>Among the 27 patients, the protein catabolic rate was 0.95+/-0.5 g/kg/day and lean body mass was 37.4+/-0.5 kg measured by the conventional method. Using BIA, the lean body mass was 37.8+/-11.0 kg with peritoneal dialysate, which was strongly correlated with the conventional method (p<0.001). BIA of lean body mass was 37.4+/-9.2 kg without peritoneal dialysate, which was also significantly correlated to the conventional method (p<0.001).</p><p><strong>Conclusions: </strong>BIA nutritional assessment of lean body mass was comparable to the conventional method of nutritional assessment. The presence or absence of peritoneal dialysate did not influence the BIA method for detection of lean body mass. BIA has the advantage of being a more simple procedure and can be used for the long-term assessment of nutritional status in CAPD patients.</p>","PeriodicalId":24073,"journal":{"name":"Zhonghua yi xue za zhi = Chinese medical journal; Free China ed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21902697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy. 口服格拉司琼加地塞米松与静脉注射昂丹司琼加地塞米松控制中/重度致吐性化疗引起的恶心呕吐的疗效和安全性比较
T J Chiou, W F Tzeng, W S Wang, C C Yen, F S Fan, J H Liu, P M Chen

Background: Chemotherapy-induced nausea and vomiting can affect cancer patients' compliance with cytotoxic chemotherapy. Currently, there are some new antiemetic therapies for the treatment of chemotherapy-induced emesis. A single institution, randomized, open, parallel trial was done to compare oral granisetron plus intravenous (i.v.) dexamethasone with intravenous ondansetron for the prevention of moderate or severe emetogenic chemotherapy-induced acute and delayed emesis.

Methods: Fifty-one cancer patients were treated with moderate/severe emetogenic chemotherapy and randomized to receive either oral granisetron 1 mg twice daily or i.v. ondansetron 8 mg every 8 hours combined with i.v. dexamethasone 10 mg on the day of chemotherapy. The efficacy and safety of the two antiemetic regimens were compared.

Results: Oral granisetron plus i.v. dexamethasone had comparable antiemetic efficacy for the prevention of nausea in the first 24-hour period after initiation of chemotherapy compared with intravenous ondansetron plus i.v. dexamethasone. The complete response of antiemesis in the first 24-hour period after initiation of antiemetic therapy between granisetron and ondansetron were 84.0% (95% CI, 62.9%-95.6%) and 84.6 (95% CI, 64.0%-97.5%). The complete response for delayed emesis after initiation of antiemetic therapy between granisetron and ondansetron were 16.0% (95% CI, 4.5%-36.1%) and 19.2% (95% CI, 6.8%-40.7%0. There was diarrhea in 12% of patients receiving granisetron therapy and constipation in 23.1% of the ondansetron group.

Conclusions: Oral granisetron plus i.v. dexamethasone and i.v. ondansetron plus i.v. dexamethasone are potentially equally effective antiemetic agents in the prevention of moderate or severe emetogenic chemotherapy-induced acute or delayed emesis. Oral granisetron with dexamethasone appears to be a suitable alternative antiemetic agent in cancer patients who receive moderately or severely emetogenic chemotherapy.

背景:化疗引起的恶心和呕吐会影响肿瘤患者对细胞毒性化疗的依从性。目前,有一些新的止吐疗法用于治疗化疗引起的呕吐。一项单机构、随机、开放、平行试验比较口服格拉司琼加静脉注射地塞米松与静脉注射昂丹司琼预防中度或重度致吐性化疗引起的急性和延迟性呕吐的效果。方法:51例肿瘤患者接受中/重度致吐性化疗,随机分为格拉司琼1 mg口服2次/ d或昂丹司琼8 mg / 8 h静脉注射,化疗当日联合地塞米松10 mg静脉注射。比较两种止吐方案的疗效和安全性。结果:口服格拉司琼加静脉注射地塞米松与静脉注射昂丹司琼加静脉注射地塞米松相比,在化疗开始后24小时内预防恶心的止吐效果相当。格拉司琼和昂丹司琼在开始止吐治疗后第一个24小时内止吐的完全缓解率分别为84.0% (95% CI, 62.9% ~ 95.6%)和84.6% (95% CI, 64.0% ~ 97.5%)。格拉司琼和昂丹司琼开始止吐治疗后迟发性呕吐的完全缓解率分别为16.0% (95% CI, 4.5%-36.1%)和19.2% (95% CI, 6.8%-40.7%)。格拉司琼组12%的患者出现腹泻,昂丹司琼组23.1%的患者出现便秘。结论:口服格拉司琼加静脉注射地塞米松和口服昂丹司琼加静脉注射地塞米松在预防中、重度致吐性化疗引起的急性或延迟性呕吐方面具有潜在的同等效果。口服格拉司琼联合地塞米松似乎是接受中度或重度致吐性化疗的癌症患者的一种合适的替代止吐剂。
{"title":"Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.","authors":"T J Chiou,&nbsp;W F Tzeng,&nbsp;W S Wang,&nbsp;C C Yen,&nbsp;F S Fan,&nbsp;J H Liu,&nbsp;P M Chen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Chemotherapy-induced nausea and vomiting can affect cancer patients' compliance with cytotoxic chemotherapy. Currently, there are some new antiemetic therapies for the treatment of chemotherapy-induced emesis. A single institution, randomized, open, parallel trial was done to compare oral granisetron plus intravenous (i.v.) dexamethasone with intravenous ondansetron for the prevention of moderate or severe emetogenic chemotherapy-induced acute and delayed emesis.</p><p><strong>Methods: </strong>Fifty-one cancer patients were treated with moderate/severe emetogenic chemotherapy and randomized to receive either oral granisetron 1 mg twice daily or i.v. ondansetron 8 mg every 8 hours combined with i.v. dexamethasone 10 mg on the day of chemotherapy. The efficacy and safety of the two antiemetic regimens were compared.</p><p><strong>Results: </strong>Oral granisetron plus i.v. dexamethasone had comparable antiemetic efficacy for the prevention of nausea in the first 24-hour period after initiation of chemotherapy compared with intravenous ondansetron plus i.v. dexamethasone. The complete response of antiemesis in the first 24-hour period after initiation of antiemetic therapy between granisetron and ondansetron were 84.0% (95% CI, 62.9%-95.6%) and 84.6 (95% CI, 64.0%-97.5%). The complete response for delayed emesis after initiation of antiemetic therapy between granisetron and ondansetron were 16.0% (95% CI, 4.5%-36.1%) and 19.2% (95% CI, 6.8%-40.7%0. There was diarrhea in 12% of patients receiving granisetron therapy and constipation in 23.1% of the ondansetron group.</p><p><strong>Conclusions: </strong>Oral granisetron plus i.v. dexamethasone and i.v. ondansetron plus i.v. dexamethasone are potentially equally effective antiemetic agents in the prevention of moderate or severe emetogenic chemotherapy-induced acute or delayed emesis. Oral granisetron with dexamethasone appears to be a suitable alternative antiemetic agent in cancer patients who receive moderately or severely emetogenic chemotherapy.</p>","PeriodicalId":24073,"journal":{"name":"Zhonghua yi xue za zhi = Chinese medical journal; Free China ed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21902693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative study of timolol gel versus timolol solution for patients with glaucoma. 替洛尔凝胶与替洛尔溶液治疗青光眼的比较研究。
S H Chiou, W M Hsu, J H Liu, J L Liu, M R Chen, D C Tsai, C K Chou

Background: The timolol gel was developed for the simplification of multi-dose medications for glaucoma patients. This gel can be used once per day instead of twice per day of the aqueous form. It is necessary to understand the clinical effects of intraocular pressure maintained in glaucoma by there two forms of timolol.

Methods: Fifty-two eligible patients were included and completed the 12-week study. In this randomized, open-label, two-period crossover study design, patients received either the gel form of 0.5% timolol once daily or the aqueous form of 0.5% timolol twice daily for the first 6 weeks, then crossed over to the other treatment form for the remaining 6 weeks. Intraocular pressure was measured at baseline, week 6 and week 12 at the end of the treatment period. The incidences of all the adverse events were recorded and summarized in each follow-up visit.

Results: No statistically significant difference in intraocular pressure was observed between the two different control treatment groups (p>0.05). However, stickiness and transient blurred vision was reported more often by patients using the gel form than the aqueous form of timolol.

Conclusions: The gel form of 0.5% timolol used once daily offers a new alternative that is probably more convenient than the aqueous form of 0.5% timolol given twice daily in maintaining the intraocular pressure of patients with glaucoma.

背景:替马洛尔凝胶是为简化青光眼患者的多剂量药物治疗而研制的。这种凝胶可以每天使用一次,而不是每天两次的水形式。了解两种噻莫洛尔维持青光眼眼压的临床效果是很有必要的。方法:纳入52例符合条件的患者并完成为期12周的研究。在这个随机、开放标签、两期交叉研究设计中,患者在前6周接受0.5%噻洛尔凝胶形式每日一次或0.5%噻洛尔水溶液形式每日两次,然后在剩下的6周中切换到另一种治疗形式。在治疗期结束时,分别在基线、第6周和第12周测量眼压。在每次随访中记录并总结所有不良事件的发生情况。结果:两组患者眼压差异无统计学意义(p>0.05)。然而,使用凝胶形式的患者比使用水形式的替马洛尔的患者更常报告粘连和短暂性视力模糊。结论:在维持青光眼患者眼压方面,每日1次的0.5%噻洛尔凝胶剂型可能比每日2次的0.5%噻洛尔水剂型更为方便。
{"title":"Comparative study of timolol gel versus timolol solution for patients with glaucoma.","authors":"S H Chiou,&nbsp;W M Hsu,&nbsp;J H Liu,&nbsp;J L Liu,&nbsp;M R Chen,&nbsp;D C Tsai,&nbsp;C K Chou","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The timolol gel was developed for the simplification of multi-dose medications for glaucoma patients. This gel can be used once per day instead of twice per day of the aqueous form. It is necessary to understand the clinical effects of intraocular pressure maintained in glaucoma by there two forms of timolol.</p><p><strong>Methods: </strong>Fifty-two eligible patients were included and completed the 12-week study. In this randomized, open-label, two-period crossover study design, patients received either the gel form of 0.5% timolol once daily or the aqueous form of 0.5% timolol twice daily for the first 6 weeks, then crossed over to the other treatment form for the remaining 6 weeks. Intraocular pressure was measured at baseline, week 6 and week 12 at the end of the treatment period. The incidences of all the adverse events were recorded and summarized in each follow-up visit.</p><p><strong>Results: </strong>No statistically significant difference in intraocular pressure was observed between the two different control treatment groups (p>0.05). However, stickiness and transient blurred vision was reported more often by patients using the gel form than the aqueous form of timolol.</p><p><strong>Conclusions: </strong>The gel form of 0.5% timolol used once daily offers a new alternative that is probably more convenient than the aqueous form of 0.5% timolol given twice daily in maintaining the intraocular pressure of patients with glaucoma.</p>","PeriodicalId":24073,"journal":{"name":"Zhonghua yi xue za zhi = Chinese medical journal; Free China ed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21902694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histopathologic analysis of sentinel lymph nodes in breast carcinoma. 乳腺癌前哨淋巴结的组织病理学分析。
P P Hsieh, W L Ho, D C Yeh, T J Liu, C C Wu, J H Lin, S J Wang

Background: Intraoperative lymphatic mapping and identification of the first draining lymph node (the sentinel lymph node) may allow some patients with breast cancer to avoid the morbidity of formal axillary clearance. The aim of this study was to determine the accuracy of sentinel lymph node (SLN) biopsy in predicting axillary nodal involvement.

Methods: From August, 1998 until July, 1999, 41 patients with clinically node-negative breast cancer underwent SLN biopsy that was immediately followed by axillary lymph node dissection. If the SLN section was found free of metastasis by routine hematoxylin and eosin staining (H&E), then an additional four sections of the SLN were cut and examined for the presence of tumor cells by H&E staining (three sections) and by cytokeratin immunohistochemical staining (IHC) (one section). If the SLN had metastatic cells and the other remaining nonsentinel axillary lymph nodes were free of metastases by routine H&E staining, then an additional three sections of the nonsentinel axillary lymph nodes were cut and examined for the presence of tumor cells by H&E staining.

Results: The 41 patients had a mean of 2.2 sentinel (range, 1-7) and 14.6 nonsentinel (range, 5-32) lymph nodes excised per patient. Routine H&E staining identified 13 patients (31.7%) with SLN metastases and 28 patients (68.3%) with tumor-free SLNs. Applying IHC and the additional three sections stained with H&E to these tumor-free SLNs showed one additional patient with sentinel node metastasis. The conversion rate from being a sentinel node-negative patient to a sentinel node-positive patient was 3.6% (1/28). Overall, SLN metastases were detected in 14 (34.1%) of the 41 patients. The SLNs were negative in 27 patients (65.9%), two of whom had at least one positive nonsentinel lymph node each (7.4% "skip" metastasis). Biopsy of SLNs was 92.6% accurate in predicting the absence of nonsentinel nodal metastasis (p=0.001).

Conclusions: Our results suggest that formal axillary lymph node dissection may need only be performed in SLN-positive patients. Nonetheless, further experience and refinement are needed to perfect this technique.

背景:术中淋巴结作图和第一个引流淋巴结(前哨淋巴结)的识别可以使一些乳腺癌患者避免正式腋窝清扫的发病率。本研究的目的是确定前哨淋巴结(SLN)活检预测腋窝淋巴结受累的准确性。方法:自1998年8月至1999年7月,41例临床淋巴结阴性乳腺癌患者行SLN活检,并立即行腋窝淋巴结清扫术。如果通过常规苏木精和伊红染色(H&E)发现SLN切片无转移,则切除另外4个SLN切片,通过H&E染色(3个切片)和细胞角蛋白免疫组化染色(IHC)(1个切片)检查肿瘤细胞的存在。如果SLN有转移细胞,其他剩余的非前哨腋窝淋巴结通过常规H&E染色无转移,则切除另外三段非前哨腋窝淋巴结,并通过H&E染色检查肿瘤细胞的存在。结果:41例患者平均切除了2.2个前哨淋巴结(范围1-7)和14.6个非前哨淋巴结(范围5-32)。常规H&E染色发现13例(31.7%)SLN转移,28例(68.3%)无肿瘤SLN。对这些无肿瘤的sln进行免疫组化和另外三个H&E染色切片显示,另外一个患者有前哨淋巴结转移。从前哨淋巴结阴性患者到前哨淋巴结阳性患者的转换率为3.6%(1/28)。总体而言,41例患者中有14例(34.1%)检测到SLN转移。27例(65.9%)患者sln为阴性,其中2例至少有1个非前哨淋巴结阳性(7.4%“跳跃性”转移)。sln活检预测无非前哨淋巴结转移的准确率为92.6% (p=0.001)。结论:我们的结果表明,正式的腋窝淋巴结清扫可能只需要在sln阳性患者中进行。尽管如此,需要进一步的经验和改进来完善这项技术。
{"title":"Histopathologic analysis of sentinel lymph nodes in breast carcinoma.","authors":"P P Hsieh,&nbsp;W L Ho,&nbsp;D C Yeh,&nbsp;T J Liu,&nbsp;C C Wu,&nbsp;J H Lin,&nbsp;S J Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Intraoperative lymphatic mapping and identification of the first draining lymph node (the sentinel lymph node) may allow some patients with breast cancer to avoid the morbidity of formal axillary clearance. The aim of this study was to determine the accuracy of sentinel lymph node (SLN) biopsy in predicting axillary nodal involvement.</p><p><strong>Methods: </strong>From August, 1998 until July, 1999, 41 patients with clinically node-negative breast cancer underwent SLN biopsy that was immediately followed by axillary lymph node dissection. If the SLN section was found free of metastasis by routine hematoxylin and eosin staining (H&E), then an additional four sections of the SLN were cut and examined for the presence of tumor cells by H&E staining (three sections) and by cytokeratin immunohistochemical staining (IHC) (one section). If the SLN had metastatic cells and the other remaining nonsentinel axillary lymph nodes were free of metastases by routine H&E staining, then an additional three sections of the nonsentinel axillary lymph nodes were cut and examined for the presence of tumor cells by H&E staining.</p><p><strong>Results: </strong>The 41 patients had a mean of 2.2 sentinel (range, 1-7) and 14.6 nonsentinel (range, 5-32) lymph nodes excised per patient. Routine H&E staining identified 13 patients (31.7%) with SLN metastases and 28 patients (68.3%) with tumor-free SLNs. Applying IHC and the additional three sections stained with H&E to these tumor-free SLNs showed one additional patient with sentinel node metastasis. The conversion rate from being a sentinel node-negative patient to a sentinel node-positive patient was 3.6% (1/28). Overall, SLN metastases were detected in 14 (34.1%) of the 41 patients. The SLNs were negative in 27 patients (65.9%), two of whom had at least one positive nonsentinel lymph node each (7.4% \"skip\" metastasis). Biopsy of SLNs was 92.6% accurate in predicting the absence of nonsentinel nodal metastasis (p=0.001).</p><p><strong>Conclusions: </strong>Our results suggest that formal axillary lymph node dissection may need only be performed in SLN-positive patients. Nonetheless, further experience and refinement are needed to perfect this technique.</p>","PeriodicalId":24073,"journal":{"name":"Zhonghua yi xue za zhi = Chinese medical journal; Free China ed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21902695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calcified schwannoma of the orbit and differential diagnosis of orbital calcification. 眼眶钙化神经鞘瘤与眼眶钙化的鉴别诊断。
S C Kao, C Y Tsai, C C Tsai, W M Hsu

Calcified schwannoma of the orbit is rarely reported in the world literature. A 38-year-old Chinese male presented with a 5-year history of slow progressive left-sided axial proptosis. A smooth, retrobulbar and intracornal mass with central calcification and high internal reflectivity was found on computed tomography and sonographic study. From the clinical and radiologic features, the presumptive diagnosis of orbital cavernous hemangioma or meningioma was made and orbitotomy with tumor exicision was performed. Tumor excision revealed the rare diagnosis of calcified schwannoma. The differential diagnoses of a calcified orbital mass and the radiologic and clinical findings of the calcified schwannoma are described and discussed.

眼眶钙化神经鞘瘤在国际文献中报道甚少。38岁中国男性,5年缓慢进行性左轴性突出病史。在计算机断层扫描和超声检查中发现光滑的球后和角状内肿块,中央钙化和高内反射率。根据临床及影像学表现,推定为眼窝海绵状血管瘤或脑膜瘤,行眼窝切开术。肿瘤切除显示罕见的钙化神经鞘瘤的诊断。眼眶钙化肿块的鉴别诊断和钙化神经鞘瘤的放射学和临床表现进行了描述和讨论。
{"title":"Calcified schwannoma of the orbit and differential diagnosis of orbital calcification.","authors":"S C Kao,&nbsp;C Y Tsai,&nbsp;C C Tsai,&nbsp;W M Hsu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Calcified schwannoma of the orbit is rarely reported in the world literature. A 38-year-old Chinese male presented with a 5-year history of slow progressive left-sided axial proptosis. A smooth, retrobulbar and intracornal mass with central calcification and high internal reflectivity was found on computed tomography and sonographic study. From the clinical and radiologic features, the presumptive diagnosis of orbital cavernous hemangioma or meningioma was made and orbitotomy with tumor exicision was performed. Tumor excision revealed the rare diagnosis of calcified schwannoma. The differential diagnoses of a calcified orbital mass and the radiologic and clinical findings of the calcified schwannoma are described and discussed.</p>","PeriodicalId":24073,"journal":{"name":"Zhonghua yi xue za zhi = Chinese medical journal; Free China ed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21901390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Klebsiella pneumoniae renal abscess. 肺炎克雷伯菌肾脓肿。
S W Chang, D H Yen, C P Fung, C Y Liu, K K Chen, C M Tiu, L M Wang, C H Lee

Background: The clinical characteristics of renal abscess caused by Klebsiella pneumoniae have not been previously reported in case-series studies. The purpose of this study is to demonstrate the clinical characteristics of K pneumoniae renal abscess for early diagnosis and to identify the clinical risk factors associating with poor prognosis.

Methods: We retrospectively reviewed the medical records of 24 patients with K pneumoniae renal abscess, from April, 1982 through February, 1998. The clinical presentations, including the demographic characteristics, predisposing disorders, initial signs and symptoms, laboratory test results, diagnostic radiology studies, therapeutic modalities and risk factors associated with mortality were studied.

Results: The mean age was 58.7 years and the male to female ratio was 10:14. The most common predisposing factors were diabetes mellitus (58%), urolithiasis (25%) and immunosuppression (17%). Fever, chills and flank pain were the most common symptoms and signs, whereas pyuria, elevation of leukocyte count, glucose, blood urea nitrogen and creatinine were the common laboratory features. The distinct complications of K pneumoniae renal abscess were bacteremia in 13 (54%), emphysematous pyelonephritis in five (21%), and metastatic septic infection in three (12.5%). The cure rate was 52% (11/21) in patients treated with a combination of antibiotics and percutaneous drainage; however, six (35%) patients who survived required another surgical procedure for complete recovery. The overall mortality rate was 25%. The clinical factors of elderly age (>65 years) at presentation, lethargy, elevation of serum blood urea nitrogen and pulmonary complications were associated with poor prognoses.

Conclusions: Focusing on the early diagnosis of K pneumoniae renal abscess and recognition of the prognostic factors for a poor prognosis, we highlight the specific clinical characteristics that include elderly age, lethargy, impairment of renal function, metastatic septic lesions and pulmonary complications. All patients with K pneumoniae renal abscesses should receive empiric antibiotics and percutaneous drainage or aspiration, and surgical intervention as necessary for patients with intractable disease.

背景:肺炎克雷伯菌引起的肾脓肿的临床特征在以前的病例系列研究中没有报道。本研究的目的是阐明肺炎克氏菌性肾脓肿的临床特点,以便早期诊断,并确定与预后不良相关的临床危险因素。方法:回顾性分析我院1982年4月至1998年2月收治的24例肺炎克氏菌性肾脓肿病例。研究了临床表现,包括人口特征、易感疾病、初始体征和症状、实验室测试结果、诊断放射学研究、治疗方式和与死亡率相关的风险因素。结果:患者平均年龄58.7岁,男女比例为10:14。最常见的易感因素是糖尿病(58%)、尿石症(25%)和免疫抑制(17%)。发热、寒战和腹部疼痛是最常见的症状和体征,而脓尿、白细胞计数、葡萄糖、血尿素氮和肌酐升高是常见的实验室特征。肺炎K菌性肾脓肿的明显并发症为13例(54%)菌血症,5例(21%)肺气性肾盂肾炎,3例(12.5%)转移性脓毒性感染。抗生素联合经皮引流治疗的治愈率为52% (11/21);然而,6例(35%)存活的患者需要再次手术才能完全恢复。总死亡率为25%。发病时年龄大于65岁、嗜睡、血清尿素氮升高、肺部并发症等临床因素与预后不良相关。结论:针对肺炎K菌性肾脓肿的早期诊断和不良预后因素的认识,我们强调了老年、嗜睡、肾功能损害、转移性脓毒症病变和肺部并发症等具体的临床特征。所有肺炎克雷伯菌肾脓肿患者应接受经验性抗生素和经皮引流或抽吸,对于难治性疾病患者,必要时应进行手术干预。
{"title":"Klebsiella pneumoniae renal abscess.","authors":"S W Chang,&nbsp;D H Yen,&nbsp;C P Fung,&nbsp;C Y Liu,&nbsp;K K Chen,&nbsp;C M Tiu,&nbsp;L M Wang,&nbsp;C H Lee","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The clinical characteristics of renal abscess caused by Klebsiella pneumoniae have not been previously reported in case-series studies. The purpose of this study is to demonstrate the clinical characteristics of K pneumoniae renal abscess for early diagnosis and to identify the clinical risk factors associating with poor prognosis.</p><p><strong>Methods: </strong>We retrospectively reviewed the medical records of 24 patients with K pneumoniae renal abscess, from April, 1982 through February, 1998. The clinical presentations, including the demographic characteristics, predisposing disorders, initial signs and symptoms, laboratory test results, diagnostic radiology studies, therapeutic modalities and risk factors associated with mortality were studied.</p><p><strong>Results: </strong>The mean age was 58.7 years and the male to female ratio was 10:14. The most common predisposing factors were diabetes mellitus (58%), urolithiasis (25%) and immunosuppression (17%). Fever, chills and flank pain were the most common symptoms and signs, whereas pyuria, elevation of leukocyte count, glucose, blood urea nitrogen and creatinine were the common laboratory features. The distinct complications of K pneumoniae renal abscess were bacteremia in 13 (54%), emphysematous pyelonephritis in five (21%), and metastatic septic infection in three (12.5%). The cure rate was 52% (11/21) in patients treated with a combination of antibiotics and percutaneous drainage; however, six (35%) patients who survived required another surgical procedure for complete recovery. The overall mortality rate was 25%. The clinical factors of elderly age (>65 years) at presentation, lethargy, elevation of serum blood urea nitrogen and pulmonary complications were associated with poor prognoses.</p><p><strong>Conclusions: </strong>Focusing on the early diagnosis of K pneumoniae renal abscess and recognition of the prognostic factors for a poor prognosis, we highlight the specific clinical characteristics that include elderly age, lethargy, impairment of renal function, metastatic septic lesions and pulmonary complications. All patients with K pneumoniae renal abscesses should receive empiric antibiotics and percutaneous drainage or aspiration, and surgical intervention as necessary for patients with intractable disease.</p>","PeriodicalId":24073,"journal":{"name":"Zhonghua yi xue za zhi = Chinese medical journal; Free China ed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21902692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Zhonghua yi xue za zhi = Chinese medical journal; Free China ed
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1